Table 2.
Variable | HW (n=63) | NHW (n=116) | Odds Ratio | 95% CI | P-value |
---|---|---|---|---|---|
MC1R Genotype | |||||
V60L | 10 (15.9) | 18 (15.5) | 1.03 | 0.44, 2.38 | 0.93 |
D84E | 0 | 2 (1.7) | Not estimable | ||
V92M | 1 (1.6) | 12 (10.3) | 0.14 | 0.02, 1.10 | 0.06 |
R142H | 0 | 2 (1.7) | Not estimable | ||
R151C | 6 (9.5) | 16 (13.8) | 0.66 | 0.24, 1.78 | 0.41 |
I155T | 2 (3.2) | 4 (3.5) | 0.92 | 0.16, 5.16 | 0.92 |
R160W | 2 (3.2) | 15 (12.9) | 0.22 | 0.49, 0.99 | 0.03 |
R163Q | 30 (47.6) | 15 (12.9) | 6.12 | 2.94, 12.75 | <0.0001 |
D294H | 1 (1.6) | 1 (0.9) | 1.86 | 0.11, 30.17 | 0.66 |
Includes those from control group who asked for genetic testing (n = 25) and those responding to the invitation for testing in the intervention group (n = 166). We excluded “Other” ethnicity participants (n=12) due to the small sample size.